Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry
Magdalena Kraft(Humboldt-Universität zu Berlin), Maria Beatrice Bilò(Marche Polytechnic University), Alice Koehli(University Children's Hospital Zurich), Iwona Poziomkowska‐Gęsicka(Pomeranian Medical University), Ewa Cichocka‐Jarosz(Jagiellonian University), Blanca E. García(Complejo Hospitalario de Navarra), Nicola Wagner(Friedrich-Alexander-Universität Erlangen-Nürnberg), Claudia Pföhler(Saarland University), Bettina Wedi(Medizinische Hochschule Hannover), Regina Treudler(Humboldt-Universität zu Berlin), Tihomir B. Mustakov, Montserrat Fernández‐Rivas(Hospital Clínico San Carlos), George Christoff(Tokuda Hospital), Andrea Bauer(University Hospital Carl Gustav Carus), Victòria Cardona(Vall d'Hebron Hospital Universitari), Luís Felipe Ensina(Universidade Federal de São Paulo), Margitta Worm(Charité - Universitätsmedizin Berlin), Anne Moeser(Jena University Hospital), Sabine Müller(Deutsche Gesellschaft für Psychoanalyse, Psychotherapie, Psychosomatik und Tiefenpsychologie), Thomas Spindler(Landwirtschaftlichen Zentrums Baden-Württemberg), Jonathan O’B Hourihane(Royal College of Surgeons in Ireland), Lars Lange(St. Marien-Hospital Bonn), Roland Lang(Paracelsus Medical University), Linus Grabenhenrich(Charité - Universitätsmedizin Berlin), Ioana Maris(University College Cork), Nikolaos G. Papadopoulos(National and Kapodistrian University of Athens), Sabine Dölle(Freie Universität Berlin), Jean‐Marie Renaudin(Réseau d'Allergo-Vigilance), Macarena Knop(LMU Klinikum), Vera Mahler(Paul Ehrlich Institut), Uta Rabe(Klinik Preetz)
Cited by 15
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision
|Journal of Allergy and Clinical Immunology|2017|2k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k